Molecule Details
| InChIKey | YTINZZFBHWSAGL-NDEPHWFRSA-N |
|---|---|
| Canonical SMILES | N#Cc1ccc(N2CCN(Cc3ccc(COc4cccc5c4CN([C@H]4CCC(=O)NC4=O)C5=O)cc3)CC2)c(F)c1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 2 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 7.52 |
| Source | ChEMBL |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB17584 |
|---|---|
| Drug Name | Mezigdomide |
| CAS Number | 2259648-80-9 |
| Groups | investigational |
| ATC Codes | nan |
| Description | Mezigdomide is under investigation in clinical trial NCT05372354 (A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma). |
Cross-references: CHEMBL4648616 ChemSpider: 84451594 PDB: QFC